Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether taking indinavir (IDV) plus ritonavir (RTV) plus
stavudine (d4T) plus lamivudine (3TC) 2 times each day is safe and can lower the level of HIV
in the blood.